Rates of Physician-Patient Discussions About Lung Cancer Screening Very Low and Declining
PHILADELPHIA: – Low rates of physician-patient discussions about lung cancer screening have declined further since 2012 and were not...
Search/Filter
Loading...
Six Factors May Predict Invasive Breast Cancer Recurrence after Ductal Carcinoma in Situ Diagnosis
PHILADELPHIA – Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in...
A Deep-learning Model May Help Predict Lung Cancer Survival and Outcomes
PHILADELPHIA: – A deep-learning model developed using serial image scans of tumors from patients with non-small cell lung cancer...
AACR Names New Editor-in-chief of Cancer Epidemiology, Biomarkers & Prevention
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the appointment of Elizabeth A. Platz,...
AACR Names New Editor-in-chief of Molecular Cancer Therapeutics
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the appointment of Beverly Teicher, PhD,...
Gum Disease and Tooth Loss Associated With Higher Risk of Pancreatic Cancer in African-American Women
PHILADELPHIA – Poor oral health was associated with increased risk of pancreatic cancer in African-American women, according to results...
Combinatorial Signature Outperforms Standard-of-care Methods in Stratifying Colorectal Cancer Patients for Prognosis
PHILADELPHIA – A method that integrates tumor buds, lymphocytic infiltration, and their spatial relationship could better stratify patients with...
Two Types of HPV Linked to Cervical Cancer Have Declined in Cervical Precancers Since the Advent of the HPV Vaccine
PHILADELPHIA – An analysis of cervical precancers over a period of seven years showed that two strains of human...
Use of Gastric Acid Suppressants May Negatively Impact Survival Outcomes in Sarcoma Patients Treated with Pazopanib
PHILADELPHIA: – In patients with soft tissue sarcoma, the concomitant use of gastric acid suppressant (GAS) therapy and the...
Patients With Distinct BRAF-mutant Melanoma Genotypes May Differentially Respond to Targeted and Immunologic Therapies
PHILADELPHIA – Unlike patients with melanoma bearing BRAF V600E mutations, those whose tumors have V600K mutations may benefit less...